Scientists have linked roughly five percent of adult cancers to mutations in genes called FOCAD and TTC37. Another gene known ...

Although Nor Haryati has finished her treatment, doctors were loathe to say she was cancer-free due to the genetic mutation.

Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

The American Cancer Society recently predicted there will be around 155,000 new cases of colorectal cancer and 52,900 deaths ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...